BYFC director receives 2,675-share stock award

JOHNS MARIE C reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

JOHNS MARIE C reported acquisition or exercise transactions in this Form 4 filing.

Broadway Financial Corporation director Marie C. Johns received an equity award of 2,675 shares of Common Stock on March 2, 2026. The award was granted at a price of $7.85 per share under the company’s amended and Restated 2018 Long Term Incentive Plan. Following this grant, Johns directly owns 10,223 shares of Broadway Financial common stock. A footnote explains that prior amounts were adjusted to reflect a reverse stock split effective October 31, 2023.

Insider Trade Summary

Grant/Award: 2,675 shares

Grant/Award 1 txn

Insider JOHNS MARIE C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,675	$7.85	$21K

Holdings After Transaction: Common Stock — 10,223 shares (Direct)

Footnotes (2)

1. F1. Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.
2. F2. The amount of securities adjusted for reverse stock split effective October 31, 2023.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BYFC director Marie C. Johns report?

Marie C. Johns reported receiving an award of 2,675 shares of Broadway Financial common stock. The grant occurred on March 2, 2026 as equity compensation, classified as a grant, award, or other acquisition rather than an open-market purchase or sale.

At what price was the BYFC stock award to Marie C. Johns recorded?

The 2,675-share award to Marie C. Johns was recorded at $7.85 per share. This reflects the value used for the equity grant under Broadway Financial’s amended and Restated 2018 Long Term Incentive Plan as disclosed in the insider transaction details.

How many BYFC shares does Marie C. Johns own after this Form 4 transaction?

After the March 2, 2026 award, Marie C. Johns directly owns 10,223 shares of Broadway Financial common stock. This total includes the newly granted 2,675 shares and reflects adjustments made for a prior reverse stock split noted in the filing footnotes.

What plan governed the BYFC stock award to director Marie C. Johns?

The stock award to Marie C. Johns was issued under Broadway Financial Corporation’s amended and Restated 2018 Long Term Incentive Plan. The filing describes the shares as unrestricted stock granted as part of this long-term incentive program rather than a market purchase transaction.

Did the BYFC insider transaction involve a purchase or a grant of shares?

The BYFC insider transaction was a grant of shares, not a market purchase. It is coded as a grant, award, or other acquisition, representing unrestricted stock issued to director Marie C. Johns under the company’s long-term incentive plan on March 2, 2026.

How did the reverse stock split affect the BYFC share figures reported?

A footnote states that the amount of securities was adjusted for a reverse stock split effective October 31, 2023. This means the share counts shown in the Form 4, including holdings after the transaction, reflect post-split numbers rather than pre-split quantities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JOHNS MARIE C

(Last) (First) (Middle)

5117 WARREN PLACE NW

(Street)

WASHINGTON DC 20016

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BROADWAY FINANCIAL CORP \DE\ [ BYFC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		A		2,675(1)	A	$7.85	10,223(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

2. The amount of securities adjusted for reverse stock split effective October 31, 2023.

	/s/Audrey Phillips, Attorney-in-Fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.